Somatostatin in inflammatory bowel disease

Intestinal inflammation is controlled by various immunomodulating cells, interacting by molecular mediators. Neuropeptides, released by enteric nerve cells and neuroendocrine mucosa cells, are able to affect several aspects of the general and intestinal immune system, with both pro- as well as anti-...

Full description

Saved in:
Bibliographic Details
Main Authors: J. D. Van Bergeijk (Author), J. H. P. Wilson (Author)
Format: Book
Published: Hindawi Limited, 1997-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8c8e9c8e9ca14d1b98c7cf326c174bd9
042 |a dc 
100 1 0 |a J. D. Van Bergeijk  |e author 
700 1 0 |a J. H. P. Wilson  |e author 
245 0 0 |a Somatostatin in inflammatory bowel disease 
260 |b Hindawi Limited,   |c 1997-01-01T00:00:00Z. 
500 |a 0962-9351 
500 |a 1466-1861 
500 |a 10.1080/09629359791424 
520 |a Intestinal inflammation is controlled by various immunomodulating cells, interacting by molecular mediators. Neuropeptides, released by enteric nerve cells and neuroendocrine mucosa cells, are able to affect several aspects of the general and intestinal immune system, with both pro- as well as anti-inflammatory activities. In inflammatory bowel disease (IBD) there is both morphological as well as experimental evidence for involvement of neuropeptides in the pathogenesis. Somatostatin is the main inhibitory peptide in inflammatory processes, and its possible role in IBD is discussed. 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Mediators of Inflammation, Vol 6, Iss 5-6, Pp 303-309 (1997) 
787 0 |n http://dx.doi.org/10.1080/09629359791424 
787 0 |n https://doaj.org/toc/0962-9351 
787 0 |n https://doaj.org/toc/1466-1861 
856 4 1 |u https://doaj.org/article/8c8e9c8e9ca14d1b98c7cf326c174bd9  |z Connect to this object online.